MicroRNA-451a is a candidate biomarker and therapeutic target for major depressive disorder
Background Increasing evidence supports the role of microRNAs (miRNAs) in major depressive disorder (MDD), but the pathophysiological mechanism remains elusive.Aims To explore the mechanism of microRNA-451a (miR-451a) in the pathology and behaviours of depression.Methods Abnormal miRNAs such as miR-...
Saved in:
Main Authors: | Yan Chen, Yun Liu, Ming Xiao, Chun Wang, Panpan Hu, Qiuchen Cao, Hu Feng, Jingfan Xu, Weixi Feng, Huaiqing Sun, Huachen Ding, Junying Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-02-01
|
Series: | General Psychiatry |
Online Access: | https://gpsych.bmj.com/content/37/1/e101291.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MicroRNA-451 as an Early Predictor of Chronic Kidney Disease in Diabetic Nephropathy
by: Mostafa Abdelsalam, et al.
Published: (2020-01-01) -
Metformin Exhibits Anti‐Inflammatory Effects by Regulating microRNA‐451/CXCL16 and B Cell Leukemia/Lymphoma 2 in Patients With Osteoarthritis
by: Nahid Alimoradi, et al.
Published: (2025-01-01) -
Role of microRNAs in Stroke and Poststroke Depression
by: Han Yan, et al.
Published: (2013-01-01) -
MicroRNA as a Potential Biomarker and Treatment Strategy for Ischemia-Reperfusion Injury
by: Mingming Cao, et al.
Published: (2021-01-01) -
MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer
by: Lei Li, et al.
Published: (2020-01-01)